Lumakras (sotorasib), first treatment for adult patients with non-small cell lung cancer whose tumors have a specific type of genetic mutation called KRAS G12C
The FDA has approved Lumakras (sotorasib) as the first treatment for adult…
Novartis announces FDA approval of MET inhibitor Tabrecta (capmatinib)for metastatic non-small cell lung cancer with METex14
Novartis has announced that the US Food and Drug Administration (FDA) approved…